All Stories

  1. The impact of chronic kidney disease on prognosis in acute stroke: unraveling the pathophysiology and clinical complexity for optimal management
  2. The global, regional, and national burden of urolithiasis in 204 countries and territories, 2000–2021: a systematic analysis for the Global Burden of Disease Study 2021
  3. Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021
  4. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  5. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
  6. Decoding the Nexus: Cellular and Molecular Mechanisms Linking Stroke and Neurotoxic Microenvironments in Brain Cancer Patients
  7. Evolucollateral dynamics in stroke: Evolutionary pathophysiology, remodelling and emerging therapeutic strategies
  8. Evaluating Machine Learning Models for Stroke Prognosis and Prediction in Atrial Fibrillation Patients: A Comprehensive Meta-Analysis
  9. The role of artificial intelligence in optimizing management of atrial fibrillation in acute ischemic stroke
  10. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  11. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  12. Global, regional, and national burden of pulmonary arterial hypertension, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  13. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
  14. The need for careful consideration of futile recanalization in acute ischemic stroke patients undergoing endovascular treatment
  15. Diagnostic Utility of N-Terminal Pro-B-Type Natriuretic Peptide in Identifying Atrial Fibrillation Post-Cryptogenic Stroke: A Systematic Review and Meta-Analysis
  16. Meta-analysis of clinical and safety profiles after reperfusion therapy in acute posterior circulation strokes: insights and implications
  17. Pre-COVID life expectancy, mortality, and burden of diseases for adults 70 years and older in Australia: a systematic analysis for the Global Burden of Disease 2019 Study
  18. Pupillometer-Based Neurological Pupil Index Differential: A Potential Predictor of Post-Stroke Delirium
  19. Introducing the Futile Recanalization Prediction Score (FRPS): A Novel Approach to Predict and Mitigate Ineffective Recanalization after Endovascular Treatment of Acute Ischemic Stroke
  20. Digital biomarkers: 3PM approach revolutionizing chronic disease management — EPMA 2024 position
  21. Burden of disease scenarios for 204 countries
  22. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  23. Advancing Understanding and Addressing Disparities in Cardiomyopathy Care in Southern Africa
  24. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  25. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a syst...
  26. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
  27. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth
  28. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  29. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
  30. Chronic kidney disease prevalence and clinical outcomes in anterior circulation acute ischemic stroke patients with reperfusion therapy: A meta‐analysis
  31. Diagnosis and Management of Atrial Fibrillation in Acute Ischemic Stroke in the Setting of Reperfusion Therapy: Insights and Strategies for Optimized Care
  32. Prevalence and Impact of Cerebral Microbleeds on Clinical and Safety Outcomes in Acute Ischaemic Stroke Patients Receiving Reperfusion Therapy: A Systematic Review and Meta-Analysis
  33. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
  34. Global burden of peripheral artery disease and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  35. Comprehensive Meta-Analysis of Futile Recanalization in Acute Ischemic Stroke Patients Undergoing Endovascular Thrombectomy: Prevalence, Factors, and Clinical Outcomes
  36. Atrial Fibrillation and Reperfusion Therapy in Acute Ischaemic Stroke Patients: Prevalence and Outcomes—A Comprehensive Systematic Review and Meta-Analysis
  37. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  38. Australia's Health Evolution: 1990-2019 Disease and Risk Factor Trends
  39. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  40. Bridging the Gap in Cancer-Related Stroke Management: Update on Therapeutic and Preventive Approaches
  41. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
  42. An Equity and Justice-Informed Ethical Framework to Guide Incidental Findings in Brain Imaging Research
  43. Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026
  44. When Two Maladies Meet: Disease Burden and Pathophysiology of Stroke in Cancer
  45. Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis
  46. Association of Lesion Topography with Functional Outcomes in Acute Ischemic Stroke Patients Considered for, or Receiving, Reperfusion Therapy: A Meta-Analysis
  47. Editorial: Telemedicine during and beyond COVID-19, volume II
  48. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  49. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis
  50. Clot Morphology in Acute Ischemic Stroke Decision Making
  51. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
  52. COVID-19 and the cardiovascular system-current knowledge and future perspectives
  53. Is Composition of Brain Clot Retrieved by Mechanical Thrombectomy Associated with Stroke Aetiology and Clinical Outcomes in Acute Ischemic Stroke?—A Systematic Review and Meta-Analysis
  54. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
  55. Incidental findings in brain imaging research: spotlight on ethical considerations
  56. Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019
  57. Telemedicine during and post-COVID 19: The insights of neurosurgery patients and physicians
  58. Optic nerve infiltration by large B-cell lymphoma
  59. Successful mechanical thrombectomy of the left superior cerebellar artery
  60. The association of transradial access and transfemoral access with procedural outcomes in acute ischemic stroke patients receiving endovascular thrombectomy: A meta-analysis
  61. Prognostic accuracy and impact of cerebral collateral status on clinical and safety outcomes in acute ischemic stroke patients receiving reperfusion therapy: a systematic meta-analysis
  62. Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)
  63. Impact of diabetes on clinical and safety outcomes in acute ischemic stroke patients receiving reperfusion therapy: A meta-analysis
  64. Incidence of white matter lesions in hospitalised COVID‐19 patients: a meta‐analysis
  65. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019
  66. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
  67. Clinical outcomes following reperfusion therapy in acute ischemic stroke patients with infective endocarditis: a systematic review
  68. Role of Neutrophil-Lymphocyte Ratio in the Prognosis of Acute Ischaemic Stroke After Reperfusion Therapy: A Systematic Review and Meta-analysis
  69. Prognostic Role of the Platelet-Lymphocyte Ratio in Acute Ischemic Stroke Patients Undergoing Reperfusion Therapy: A Meta-Analysis
  70. Cardiovascular Complications of COVID-19
  71. Diagnostic and prognostic utility of brain collaterals in acute ischaemic stroke: Current knowledge and insights on treatment decision-making
  72. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
  73. Prevalence and impact of diabetes in hospitalized COVID‐19 patients: A systematic review and meta‐analysis
  74. Prevalence of paediatric hyperinflammatory conditions in paediatric and adolescent hospitalised COVID‐19 patients: a systematic review and meta‐analysis
  75. A Multicentre Study Comparing Cerebrovascular Disease Profiles in Pacific Islander and Caucasian Populations Presenting with Stroke and Transient Ischaemic Attack
  76. Brain atrophy in acute ischaemic stroke patients treated with reperfusion therapy: a systematic review
  77. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  78. Stroke Aetiology and Collateral Status in Acute Ischemic Stroke Patients Receiving Reperfusion Therapy—A Meta-Analysis
  79. Creutzfeldt-Jakob Disease in South West Sydney 2014–2020: An Unusually High Incidence of a Rare Disease
  80. Value of pre-intervention CT perfusion imaging in acute ischemic stroke prognosis
  81. Stroke in Patients with Diabetes: Is It Time to Expand Public Health Priority to Encompass High-Risk Patients with Increased Insulin Resistance?
  82. Optimising Prehospital Pathways to Improve Acute Stroke Reperfusion Therapy Delivery: Systems-Based Approaches
  83. In‐hospital prevalence of mucormycosis among coronavirus disease 2019 (COVID‐19) patients and COVID‐19 in mucormycosis: a systematic review and meta‐analysis
  84. Acute Ischaemic Stroke in Infective Endocarditis: Pathophysiology and Clinical Outcomes in Patients Treated with Reperfusion Therapy
  85. Hypertensive urgencies during the first wave of COVID-19 pandemic in a tertiary hospital setting: A “U” shaped alarming curve.
  86. Digital subtraction angiography in cerebrovascular disease: current practice and perspectives on diagnosis, acute treatment and prognosis
  87. Role of Diabetes in Stroke: Recent Advances in Pathophysiology and Clinical Management
  88. Tracking development assistance for health and for COVID-19
  89. Leukoaraiosis severity and post‐reperfusion outcomes in acute ischaemic stroke: A meta‐analysis
  90. Value of pre-intervention computed tomography perfusion imaging in the assessment of tissue outcome and long-term clinical prognosis in patients with anterior circulation acute ischemic stroke receiving reperfusion therapy: a systematic review
  91. Measuring routine childhood vaccination coverage in 204 countries and territories
  92. Emerging role of white matter lesions in cerebrovascular disease
  93. Neutrophil–lymphocyte ratio in acute ischemic stroke: Immunopathology, management, and prognosis
  94. In‐hospital systems interventions in acute stroke reperfusion therapy: a meta‐analysis
  95. Hyperdense MCA (HDMCA) sign in acute ischemic stroke patients receiving reperfusion therapy
  96. Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)
  97. Diagnostic and Prognostic Utility of CT Perfusion Imaging in Posterior Circulation Acute Ischemic Stroke: A Systematic Review and Meta‐Analysis
  98. Is COVID-19 Another Case of Obesity Paradox? - Results from An International Ecological Study on behalf of the REPROGRAM Consortium Obesity
  99. Practical Design of Flow Meter for Mechanical Ventilation Equipment
  100. Effect of prehospital workflow optimization on treatment delays and clinical outcomes in acute ischemic stroke: A systematic review and meta‐analysis
  101. Editorial: Telemedicine During and Beyond COVID-19
  102. Telemedicine During and Beyond COVID-19
  103. Call for Action to Address Equity and Justice Divide During COVID-19
  104. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
  105. CTP‐guided reperfusion therapy in acute ischemic stroke: a meta‐analysis
  106. Addressing the Covid-19 Burden on Medical Education and Training: The Role of Telemedicine and Tele-Education During and Beyond the Pandemic
  107. At the Epicenter of COVID-19–the Tragic Failure of the Global Supply Chain for Medical Supplies
  108. Designing Futuristic Telemedicine Using Artificial Intelligence and Robotics in the COVID-19 Era
  109. Telemedicine Across the Globe-Position Paper From the COVID-19 Pandemic Health System Resilience PROGRAM (REPROGRAM) International Consortium (Part 1)
  110. In‐hospital acute stroke workflow in acute stroke – Systems‐based approaches
  111. Cerebral collaterals in acute ischaemia: Implications for acute ischaemic stroke patients receiving reperfusion therapy
  112. Telemedicine as the New Outpatient Clinic Gone Digital: Position Paper From the Pandemic Health System REsilience PROGRAM (REPROGRAM) International Consortium (Part 2)
  113. Separating posterior-circulation stroke from vestibular neuritis with quantitative vestibular testing
  114. Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper
  115. Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium
  116. Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium
  117. Acute Neurological Care in the COVID-19 Era: The Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium Pathway
  118. Comparison of ABC Methods with Computerized Estimates of Intracerebral Hemorrhage Volume: The INTERACT2 Study
  119. Hemiprosopometamorphopsia: a Case of Impaired Facial Perception Restricted to the Eye
  120. Impact of obesity-induced type 2 diabetes on long-term outcomes following stroke
  121. Trends in acute stroke presentations to an emergency department: implications for specific communities in accessing acute stroke care services
  122. Clot Histopathology in Ischemic Stroke with Infective Endocarditis
  123. Reperfusion therapy in acute ischemic stroke: dawn of a new era?
  124. Factors Associated with Stroke Misdiagnosis in the Emergency Department: A Retrospective Case-Control Study
  125. Clarion call for histopathological clot analysis in “cryptogenic” ischemic stroke: implications for diagnosis and treatment
  126. The influence of initial stroke severity on mortality, overall functional outcome and in-hospital placement at 90 days following acute ischemic stroke: A tertiary hospital stroke register study
  127. Association of Cortical Vein Filling with Clot Location and Clinical Outcomes in Acute Ischaemic Stroke Patients
  128. Baseline collateral status and infarct topography in post-ischaemic perilesional hyperperfusion: An arterial spin labelling study
  129. Delay of late-venous phase cortical vein filling in acute ischemic stroke patients: Associations with collateral status
  130. Recent progress in migraine pathophysiology: role of cortical spreading depression and magnetic resonance imaging
  131. Cancer stem cells in solid tumors
  132. Towards an Intelligent Wheelchair System for Users With Cerebral Palsy
  133. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging